Internal Medicine, Medical Oncology · Rockwall, TX
NPI
1730370875
Since 2007
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
3144 Horizon Rd Ste 110
Rockwall, TX, 75032
Phone (972) 771-3322
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.2M
118,367 services
Medicare patients, 2024
568
Average age 75
Drug cost, 2024
$2.5M
2,032 prescriptions
Company payments, 2025
$581
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Scott R Seals was code J1453 (injection, fosaprepitant, 1 mg), 14,400 times for 34 patients. In total Scott R Seals billed 118,367 services in 153 codes, and Medicare paid $2.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1453 Injection, fosaprepitant, 1 mg | Office | 14,400 | 34 | $0.11 | $1,608 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 14,200 | 22 | $44.73 | $635K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 10,995 | 12 | $2.35 | $26K |
| J9267 Injection, paclitaxel, 1 mg | Office | 7,049 | 17 | $0.08 | $549 |
| J1756 Injection, iron sucrose, 1 mg | Office | 6,400 | 13 | $0.16 | $1,021 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,732 | 55 | $0.09 | $153 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,230 | 41 | $0.73 | $900 |
| 85025 Blood Count | Office | 887 | 288 | $7.59 | $6,736 |
| 36415 Venipuncture Blood Collection | Office | 852 | 269 | $8.64 | $7,362 |
| 80053 Clinical Chemistry | Office | 801 | 271 | $10.34 | $8,282 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 790 | 29 | $0.24 | $192 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 555 | 261 | $11.59 | $6,434 |
| 99213 Office E&M - Established | Office | 505 | 251 | $63.24 | $32K |
| G6015 Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 429 | 55 | $260.98 | $112K |
| 99214 Office E&M - Established | Office | 389 | 161 | $90.26 | $35K |
By year: 2022 $1.5M for 96,662 services; 2023 $1.8M for 129,357 services; 2024 $2.2M for 118,367 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 887 | 288 | $7.59 | $6,736 |
| 36415 Venipuncture Blood Collection | 852 | 269 | $8.64 | $7,362 |
| 80053 Clinical Chemistry | 801 | 271 | $10.34 | $8,282 |
| 82784 Immunoassay | 192 | 18 | $8.91 | $1,711 |
| 83521 Immunoassay | 134 | 17 | $16.54 | $2,216 |
| 82728 Clinical Chemistry | 132 | 77 | $13.36 | $1,764 |
| 83540 Clinical Chemistry | 109 | 68 | $6.34 | $691 |
| 83550 Clinical Chemistry | 109 | 68 | $8.57 | $934 |
| 85055 Blood Count | 77 | 40 | $35.03 | $2,697 |
| 85007 Blood Count | 53 | 19 | $3.72 | $197 |
Medicare prescription drug claims, 2024
In 2024, the drug Scott R Seals prescribed most often to Medicare patients was Prednisone, with 116 prescriptions and refills. In total Scott R Seals wrote 2,032 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 116 | 127 | 30 | $404 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 111 | 111 | 37 | $5,121 |
| Ondansetron Hcl Generic | 97 | 99 | 56 | $839 |
| Anastrozole Generic | 84 | 164 | 23 | $1,160 |
| Letrozole Generic | 78 | 175 | 25 | $1,433 |
| Imbruvica Ibrutinib | 73 | 73 | Under 11 | $1.0M |
| Dexamethasone Generic | 65 | 81 | 28 | $1,017 |
| Eliquis Apixaban | 57 | 65 | Under 11 | $36K |
| Potassium Chloride Generic | 56 | 68 | 19 | $330 |
| Promethazine Hcl Generic | 55 | 55 | 22 | $405 |
| Zolpidem Tartrate Generic | 52 | 52 | 14 | $466 |
| Gabapentin Generic | 48 | 57 | 11 | $507 |
| Olanzapine Generic | 47 | 47 | 24 | $310 |
| Hydroxyurea Generic | 43 | 72 | Under 11 | $667 |
| Oxybutynin Chloride Generic | 37 | 53 | Under 11 | $305 |
Brand drugs: 267 claims; generic drugs: 1,765 claims; opioid claims: 223.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Scott R Seals $581 ($581 in general payments such as food, travel and fees) from 12 companies. The largest payer was Novartis Pharmaceuticals Corporation with $157.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 8 | $157 |
| Alnylam Pharmaceuticals Inc. ALNY | 3 | $73.66 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $71.15 |
| Tempus AI, Inc TEM | 3 | $62.95 |
| Array Biopharma Inc PFE | 2 | $45.4 |
| Incyte Corporation INCY | 2 | $37.9 |
| PharmaEssentia USA Corporation 6446.TW | 1 | $34.39 |
| Pfizer Inc. PFE | 2 | $33.44 |
| Kite Pharma, Inc. GILD | 1 | $19.47 |
| BeOne Medicines USA, Inc. ONC | 1 | $16.13 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.